-
ABPI Website
- International, trade and IP
International, trade and IP
To secure its position as a life science superpower, the UK will need to increase its influence on the global stage by providing international leadership on issues of importance to the life science industry. Furthermore, it is vital that the UK’s domestic policies ensure that it can remain competitive versus other leading life science hubs.
International research
To address the major health challenges of our time, the global pharmaceutical sector is pioneering cutting-edge science that can help develop new treatments and cures for diseases from cancer to dementia, as well as preventing disease through the latest generation of vaccines.
Intellectual property (IP)
The fundamental role of IP for protecting and promoting UK scientific innovation and securing the UK’s ambition to be a life science super power
International trade
The UK’s international trading relationships with existing and future partners is fundamental to the continued success of the life sciences and sustainable, resilient supply of medicines for the NHS.
International regulation
The UK is part of an increasingly competitive and changing global ecosystem. Regulatory regimes need to be dynamic and constantly evolving to adapt to the latest scientific and technological advances, as well as factors such as environmental sustainability and data privacy.
International, trade and IP publications
-
Facilitating trade in health products through international manufacturing recognition and harmonisation policy
The UK can bolster its position as a leader in life sciences by charting a pragmatic approach towards, and engaging purposefully with, a global recognition policy for manufacturing.
-
Building the UK’s international research collaborations
International research collaborations are fundamental to the discovery and early development of new medicines and vaccines.
-
WTO Twelfth Ministerial Conference: A Critical Opportunity to Strengthen the Global Trade and Health Agenda
The WTO’s Twelfth Ministerial Conference (MC12) presents an opportunity for WTO members to formalize and pursue a robust trade and health agenda that builds on these principles and further strengthens the open and rules-based international trading system in response to COVID-19 and future health crises.
-
Creating trade policy for a life sciences superpower
To achieve the Government’s ambition for the UK to thrive as a life sciences superpower, the Association of the British Pharmaceutical Industry (ABPI) believes the Government should establish three core pillars for its trade policy for pharmaceuticals.
-
Global health and the pharmaceutical industry
In countries across the world, millions of people are dying unnecessarily each year from diseases that can easily be prevented or effectively treated. This booklet explains the pharmaceutical industry's approach to some of the complicated issues surrounding world health. It demonstrates the work that companies are undertaking to improve health in poor nations and looks ahead to what more may be done in the future.